Introduction
Low birth weight (LBW) and fetal growth restriction (FGR) are associated with increased perinatal morbidity and mortality [1] , short-term and long-term childhood morbidity [2, 3] , and a range of cardiovascular and metabolic diseases in later life [4] . Whether we can predict LBW and FGR prenatally is controversial. Several maternal biochemical markers such as pregnancyassociated plasma protein-A (PAPP-A), human placental lactogen, and human chorionic gonadotropin (hCG) are reported to be related to birth weight and gestational age at delivery, but results were not conclusive [5, 6] . PAPP-A is a protein derived from trophoblasts in early pregnancy. Since fetal growth is known to be correlated with placental function, there are some reports that low PAPP-A may be associated with pregnancy complicated by LBW and FGR [7, 8] , although this is controversial [9] . When PAPP-A is combined with maternal age, maternal serum free -hCG, and fetal nuchal translucency (NT) thickness for prenatal screening of Down syndrome, the accuracy is greater than that of biochemical screening alone in the second trimester. It is reported that the detection rate for Down syndrome is 89% at a 5% false-positive rate [10] . Currently, this test is quite popular in our hospital. The aim of this study 
Materials and Methods

Sample collection
Between April 1999 and December 2003, we collected data from all non-smoking women with a singleton pregnancy who underwent screening for Down syndrome in the first trimester and who subsequently delivered at the Cathay General Hospital, Taipei. We excluded pregnancies in which any of the following was present: incomplete or incorrect chart record (35 cases), chromosomal abnormalities (9 cases), major structural abnormalities (15 cases), abortion at less than 24 weeks' gestation (23 cases), and major maternal disease (18 cases). A total of 3,089 pregnancies were enrolled into the study.
First-trimester Down syndrome screening
Screening for Down syndrome at 10-13 weeks of gestation was offered to pregnant women who came to Cathay General Hospital for prenatal care after April 1999. Fetal NT thickness and crown-rump length (CRL) were measured by one of three experienced sonographers. Fetal NT thickness was measured when CRL was between 36 and 76 mm, equivalent to a gestational age of 10 weeks 4 days to 13 weeks 6 days. The procedure followed the criteria published by the UK Fetal Medicine Foundation [11] . Because the discrepancy in gestational age calculated from last menstrual period (LMP) and CRL was quite large in some pregnancies, we converted the CRL to equivalent days of gestational age to define the percentile of birth weight. The equation used, which has been well established in our hospital from women with date discrepancy between LMP and CRL of less than 1 week, is: Predicted gestational age in days = 54.62334 + 0.55155 CRL (mm) Maternal serum PAPP-A level was determined on the same day as fetal NT measurement, using a microtiterplate enzyme-linked immunosorbent assay according to the manufacturer's protocol (Genemed Biotechnologies Inc, South San Francisco, CA, USA). Maternal serum PAPP-A levels are presented as multiples of median (MoM).
Data analysis
After correction of gestational age using the equation above, we divided our study population into the following groups: three FGR groups defined as women with a live born baby below the 10 th , 5 th , or 3 rd centile, respectively, of birth weight at the gestational week of delivery; a LBW group defined as those with infants of birth weight less than 2,500 g; and a control group of all other women.
Statistical analysis
The Chi-squared test and t test were used to compare PAPP-A between subgroups and controls. Multivariate logistic regression models were built to explore the relationship among different variables. Receiver operating characteristic (ROC) curves were drawn to determine the cut-off MoM values for PAPP-A. A p value of less than 0.05 was considered statistically significant. All statistical analyses were performed using SPSS version 11.5 (SPSS Inc, Chicago, IL, USA).
Results
In this study, the mean maternal age was 29.8 years (range, 17-43 years) and 52.1% of women were primigravidae. The mean maternal serum PAPP-A level was significantly lower in the FGR groups (< 10 th centile, 
Discussion
We demonstrated that low first trimester maternal serum PAPP-A level was significantly correlated with LBW and FGR. PAPP-A is a maternal serum protein originally isolated in 1974 by Lin et al [12] . It is derived from syncytiotrophoblasts [13] and acts as a protease for binding proteins of insulin-like growth factor (IGFBP-4) [14] . Since it breaks down IGFBP, resulting in elevation of free IGFs, low PAPP-A level indicates low IGF level and, therefore, affects birth weight [14, 15] . Maternal PAPP-A level is high in multiple pregnancies, primigravida pregnancies [16] , and intrauterine insemination pregnancies [17] . A low PAPP-A level reportedly correlates with smoking [18] , abnormal fetal karyotype [19] , early pregnancy failure [5, 8, 20, 21] , intrauterine fetal death [5, 7] , LBW [8, 18, 22] , FGR [5, 7, 23, 24] , preterm labor [7] , and pre-eclampsia [5, 25] FGR at a PAPP-A cut-off of the 5 th centile is 2.9 [7] . The relative risks of FGR from these two reports were similar but higher than those of this study (2.5, 1.8, and 2.0 at PAPP-A cut-offs of 0.3 MoM, 0.5 MoM, and the 5 th centile, respectively). Although our study showed that a low level of PAPP-A was associated with a higher relative risk of LBW and FGR, the sensitivities according to the cut-offs were quite low. At a PAPP-A cut-off of 0.5 MoM, the sensitivities of detecting subsequent LBW and FGR were between 16.2% and 22.5%, and the specificities were around 86%. However, when the PAPP-A cut-off was 0. In conclusion, we demonstrated that low maternal serum PAPP-A level in the first trimester was associated with pregnancy complicated by LBW and FGR, but the sensitivity was low. As a single marker, PAPP-A is not sufficient to predict LBW and FGR. 
